The Role of PI3K Inhibition in the Treatment of Breast Cancer, Alone or Combined With Immune Checkpoint Inhibitors

Dysregulation of phosphoinositide 3-kinase (PI3K) signaling is highly implicated in tumorigenesis, disease progression, and the development of resistance to the current standard of care treatments in breast cancer patients. This review discusses the role of PI3K pathway in breast cancer and evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhizhu, Richmond, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139556/
https://www.ncbi.nlm.nih.gov/pubmed/34026830
http://dx.doi.org/10.3389/fmolb.2021.648663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139556/
https://www.ncbi.nlm.nih.gov/pubmed/34026830
http://dx.doi.org/10.3389/fmolb.2021.648663

Ejemplares similares